NCT04619875View on ClinicalTrials.gov

A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

November 21, 2017

Study Completion Date

November 21, 2017

Conditions
Healthy
Interventions
OTHER

KB5

KB5, a novel glycan, is a Kaleido laboratory code for KB174

OTHER

SG1

SG1 is a novel glycan

OTHER

Lactulose

Lactulose is a synthetic dissacharide

Trial Locations (1)

60101

Biofortis, Addison

Sponsors
All Listed Sponsors
lead

Kaleido Biosciences

INDUSTRY